CICC International: First coverage of BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED (00325.HK) with "Outperform" rating, target price of HKD 195.

According to the Zhixin Finance and Economics APP, it was reported that Industrial and Commercial International has issued a research report stating that it has initiated coverage on Blue Core (00325.HK) with an "outperform" rating and a target price of 195 Hong Kong dollars. The bank believes that the group's market-leading position, unique business model, and stable profit growth are reflected in its reasonable price. The bank expects that with the support of a compound annual growth rate of 48% in revenue for the fiscal years 2025-27, the compound annual growth rate of profits during this period will reach 49%. The bank's profit assumptions are based on sustainable sales growth of assembled role-playing toys, benefiting from its strong intellectual property, continuously improving production efficiency, and global expansion.